Los Angeles Capital Management LLC Takes $288,000 Position in Lifevantage Corporation $LFVN

Los Angeles Capital Management LLC bought a new stake in shares of Lifevantage Corporation (NASDAQ:LFVN) during the 2nd quarter, HoldingsChannel reports. The institutional investor bought 22,035 shares of the company’s stock, valued at approximately $288,000.

Other hedge funds have also added to or reduced their stakes in the company. Capital Management Corp VA lifted its stake in Lifevantage by 77.0% in the second quarter. Capital Management Corp VA now owns 1,266,110 shares of the company’s stock valued at $16,561,000 after buying an additional 550,607 shares during the period. Driehaus Capital Management LLC acquired a new position in shares of Lifevantage during the 1st quarter valued at $6,701,000. Russell Investments Group Ltd. boosted its stake in Lifevantage by 393,513.8% during the first quarter. Russell Investments Group Ltd. now owns 114,148 shares of the company’s stock worth $1,664,000 after acquiring an additional 114,119 shares in the last quarter. Trexquant Investment LP acquired a new stake in Lifevantage in the first quarter worth $1,607,000. Finally, Acadian Asset Management LLC grew its holdings in Lifevantage by 47.3% in the first quarter. Acadian Asset Management LLC now owns 291,700 shares of the company’s stock worth $4,248,000 after purchasing an additional 93,661 shares during the period. 35.32% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other news, Director Michael A. Beindorff sold 35,000 shares of the stock in a transaction that occurred on Friday, November 7th. The shares were sold at an average price of $6.92, for a total transaction of $242,200.00. Following the completion of the transaction, the director directly owned 56,413 shares of the company’s stock, valued at $390,377.96. This represents a 38.29% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders have sold 40,325 shares of company stock valued at $298,990 in the last 90 days. 21.95% of the stock is owned by insiders.

Lifevantage Trading Up 2.3%

Shares of Lifevantage stock opened at $6.62 on Monday. The stock has a fifty day simple moving average of $9.12 and a 200 day simple moving average of $11.54. The company has a market capitalization of $84.08 million, a P/E ratio of 8.95 and a beta of 0.22. Lifevantage Corporation has a 12-month low of $6.38 and a 12-month high of $27.38.

Lifevantage (NASDAQ:LFVN) last posted its earnings results on Tuesday, November 4th. The company reported $0.18 EPS for the quarter, topping the consensus estimate of $0.17 by $0.01. Lifevantage had a net margin of 4.29% and a return on equity of 33.75%. The firm had revenue of $47.56 million for the quarter, compared to analysts’ expectations of $54.74 million. Lifevantage has set its FY 2026 guidance at 1.000-1.150 EPS.

Lifevantage Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, December 15th. Shareholders of record on Monday, December 1st will be given a $0.045 dividend. The ex-dividend date of this dividend is Monday, December 1st. This represents a $0.18 annualized dividend and a yield of 2.7%. Lifevantage’s payout ratio is currently 23.38%.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on LFVN shares. Weiss Ratings reissued a “hold (c+)” rating on shares of Lifevantage in a research report on Wednesday, October 8th. Lake Street Capital reaffirmed a “buy” rating and set a $12.00 target price on shares of Lifevantage in a research report on Wednesday, November 5th. Finally, Wall Street Zen downgraded shares of Lifevantage from a “buy” rating to a “hold” rating in a research report on Saturday, November 8th. Two investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $23.50.

Lifevantage Company Profile

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.